0 followers
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular ther... Read more
Bruce Culleton
Focus Staff
12 followers
Poplin
84 followers
Furst Group
12 followers
Jeeves
5 followers
Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem)
1 follower
BorderX Lab
2 followers
Bangor International Airport
2 followers
Twist Bioscience
11 followers
Gartner
772 followers
Stanley Black & Decker
67 followers
USPS
70 followers
Explore companies